Soy isoflavones and breast cancer cell lines: Molecular mechanisms and future perspectives

Molecules

Volumn 21, Issue 1, 2016, Pages

  Uifəlean, Alina ^a,b   Schneider, Stefanie ^b   Ionescu, Corina ^a   Lalk, Michael ^b   Iuga, Cristina Adela ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Breast cancer; Estrogen receptor; Genistein; Isoflavone; Molecular mechanism

Indexed keywords

EID: 85000786977     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21010013     Document Type: Review

References (106)

1. Siegel, R.; Ma, J.; Zou, Z.; Jemal, A. Cancer statistics, 2014. CA: Cancer J. Clin. 2014, 64, 9-29. [CrossRef] [PubMed].
2. Burstein, H.J.; Temin, S.; Anderson, H.; Buchholz, T.A.; Davidson, N.E.; Gelmon, K.E.; Giordano, S.H.; Hudis, C.A.; Rowden, D.; Solky, A.J.; et al. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American society of clinical oncology clinical practice guideline focused update. J. Clin. Oncol. 2014, 32, 2255-2269. [CrossRef] [PubMed].
3. Hankinson, S.E.; Colditz, G.A.; Willett, W.C. Towards an integrated model for breast cancer etiology: The lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res. 2004, 6, 213-218. [CrossRef] [PubMed].
4. Hammond, M.E.; Hayes, D.F.; Dowsett, M.; Allred, D.C.; Hagerty, K.L.; Badve, S.; Fitzgibbons, P.L.; Francis, G.; Goldstein, N.S.; Hayes, M.; et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch. Pathol. Lab. Med. 2010, 134, e48-e72. [PubMed].
5. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005, 365, 1687-1717.
6. Howlader, N.; Noone, A.M.; Krapcho, M.; Neyman, N.; Aminou, R.; Waldron, W.; Altekruse, S.F.; Kosary, C.L.; Ruhl, J.; Tatalovich, Z.; et al. SEER Cancer Statistics Review, 1975-2008; National Cancer Institute: Bethesda, MD, USA, 2011.
7. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA: Cancer J. Clin. 2011, 61, 69-90. [CrossRef] [PubMed].
8. Deapen, D.; Liu, L.; Perkins, C.; Bernstein, L.; Ross, R.K. Rapidly rising breast cancer incidence rates among Asian-American women. Int. J. Cancer 2002, 99, 747-750. [CrossRef] [PubMed].
9. Xiao, C.W. Health effects of soy protein and isoflavones in humans. J. Nutr. 2008, 138, 1244S-1249S. [PubMed].
10. Dong, J.Y.; Qin, L.Q. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: A meta-analysis of prospective studies. Breast Cancer Res. Treat. 2011, 125, 315-323. [CrossRef] [PubMed].
11. Xie, Q.; Chen, M.L.; Qin, Y.; Zhang, Q.Y.; Xu, H.X.; Zhou, Y.; Mi, M.T.; Zhu, J.D. Isoflavone consumption and risk of breast cancer: A dose-response meta-analysis of observational studies. Asia Pac. J. Clin. Nutr. 2013, 22, 118-127. [PubMed].
12. Fang, C.Y.; Tseng, M.; Daly, M.B. Correlates of soy food consumption in women at increased risk for breast cancer. J. Am. Diet. Assoc. 2005, 105, 1552-1558. [CrossRef] [PubMed].
13. Lammersfeld, C.A.; King, J.; Walker, S.; Vashi, P.G.; Grutsch, J.F.; Lis, C.G.; Gupta, D. Prevalence, sources, and predictors of soy consumption in breast cancer. Nutr. J. 2009, 8. [CrossRef] [PubMed].
14. He, F.J.; Chen, J.Q. Consumption of soybean, soy foods, soy isoflavones and breast cancer incidence: Differences between Chinese women and women in Western countries and possible mechanisms. Food Sci. Hum. Wellness 2013, 2, 146-161. [CrossRef].
15. Cvejić, J.; Bursać, M.; Atanacković, M. Chapter 1-Phytoestrogens: "Estrogene-Like" Phytochemicals. In Studies in Natural Products Chemistry; Atta ur, R., Ed.; Elsevier: Oxford, UK, 2012; Volume 38, pp. 1-35.
16. Pan, H.; Zhou, W.; He, W.; Liu, X.; Ding, Q.; Ling, L.; Zha, X.; Wang, S. Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-kB activity via the Notch-1 pathway. Int. J. Mol. Med. 2012, 30, 337-343. [PubMed].
17. Li, Z.; Li, J.; Mo, B.; Hu, C.; Liu, H.; Qi, H.;Wang, X.; Xu, J. Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway. Toxicol. In Vitro 2008, 22, 1749-1753. [CrossRef] [PubMed].
18. Satih, S.; Chalabi, N.; Rabiau, N.; Bosviel, R.; Fontana, L.; Bignon, Y.J.; Bernard-Gallon, D.J. Gene expression profiling of breast cancer cell lines in response to soy isoflavones using a pangenomic microarray approach. Omics 2010, 14, 231-238. [CrossRef] [PubMed].
19. Akiyama, T.; Ishida, J.; Nakagawa, S.; Ogawara, H.; Watanabe, S.; Itoh, N.; Shibuya, M.; Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 1987, 262, 5592-5595. [PubMed].
20. Markovits, J.; Linassier, C.; Fosse, P.; Couprie, J.; Pierre, J.; Jacquemin-Sablon, A.; Saucier, J.M.; le Pecq, J.B.; Larsen, A.K. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res. 1989, 49, 5111-5117. [PubMed].
21. Leung, H.Y.; Yung, L.H.; Poon, C.H.; Shi, G.; Lu, A.L.; Leung, L.K. Genistein protects against polycyclic aromatic hydrocarbon-induced oxidative DNA damage in non-cancerous breast cells MCF-10A. Br. J. Nutr. 2009, 101, 257-262. [CrossRef] [PubMed].
22. Prietsch, R.F.; Monte, L.G.; da Silva, F.A.; Beira, F.T.; del Pino, F.A.; Campos, V.F.; Collares, T.; Pinto, L.S.; Spanevello, R.M.; Gamaro, G.D.; et al. Genistein induces apoptosis and autophagy in human breast MCF-7 cells by modulating the expression of proapoptotic factors and oxidative stress enzymes. Mol. Cell. Biochem. 2014, 390, 235-242. [CrossRef] [PubMed].
23. Yu, X.; Zhu, J.; Mi, M.; Chen, W.; Pan, Q.; Wei, M. Anti-angiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation. Med. Oncol. 2012, 29, 349-357. [CrossRef] [PubMed].
24. Migliaccio, A.; di Domenico, M.; Castoria, G.; de Falco, A.; Bontempo, P.; Nola, E.; Auricchio, F. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 1996, 15, 1292-1300. [PubMed].
25. Castoria, G.; Migliaccio, A.; Bilancio, A.; di Domenico, M.; de Falco, A.; Lombardi, M.; Fiorentino, R.; Varricchio, L.; Barone, M.V.; Auricchio, F. Pi3-kinase in concert with SRC promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 2001, 20, 6050-6059. [CrossRef] [PubMed].
26. Thomas, C.; Gustafsson, J.A. The different roles of ER subtypes in cancer biology and therapy. Nat. Rev. Cancer 2011, 11, 597-608. [CrossRef] [PubMed].
27. Kuiper, G.G.; Lemmen, J.G.; Carlsson, B.; Corton, J.C.; Safe, S.H.; van der Saag, P.T.; van der Burg, B.; Gustafsson, J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139, 4252-4263. [PubMed].
28. Jefferson, W.N.; Padilla-Banks, E.; Clark, G.; Newbold, R.R. Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. J. Chromatogr. B 2002, 777, 179-189. [CrossRef].
29. Sotoca, A.M.; Ratman, D.; van der Saag, P.; Ström, A.; Gustafsson, J.A.; Vervoort, J.; Rietjens, I.M.C.M.; Murk, A.J. Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERα/ERβ ratio. J. Steroid Biochem. 2008, 112, 171-178. [CrossRef] [PubMed].
30. Muthyala, R.S.; Ju, Y.H.; Sheng, S.; Williams, L.D.; Doerge, D.R.; Katzenellenbogen, B.S.; Helferich, W.G.; Katzenellenbogen, J.A. Equol, a natural estrogenic metabolite from soy isoflavones: Convenient preparation and resolution of R- And S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg. Med. Chem. 2004, 12, 1559-1567. [CrossRef] [PubMed].
31. Leygue, E.; Dotzlaw, H.; Watson, P.H.; Murphy, L.C. Altered Estrogen Receptor α and β Messenger RNA Expression during Human Breast Tumorigenesis. Cancer Res. 1998, 58, 3197-3201. [PubMed].
32. Pons, D.G.; Nadal-Serrano, M.; Blanquer-Rossello, M.M.; Sastre-Serra, J.; Oliver, J.; Roca, P. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio. J. Cell. Biochem. 2014, 115, 949-958. [CrossRef] [PubMed].
33. Nadal-Serrano, M.; Pons, D.G.; Sastre-Serra, J.; Blanquer-Rosselló, M.D.M.; Roca, P.; Oliver, J. Genistein modulates oxidative stress in breast cancer cell lines according to ER-/ER- ratio: Effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes. Int. J. Biochem. Cell B. 2013, 45, 2045-2051. [CrossRef] [PubMed].
34. Dip, R.; Lenz, S.; Antignac, J.P.; Le Bizec, B.; Gmuender, H.; Naegeli, H. Global gene expression profiles induced by phytoestrogens in human breast cancer cells. Endocr. Relat. Cancer 2008, 15, 161-173. [CrossRef] [PubMed].
35. Sotoca, A.M.; Gelpke, M.D.; Boeren, S.; Strom, A.; Gustafsson, J.A.; Murk, A.J.; Rietjens, I.M.; Vervoort, J. Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein. Mol. Cell. Proteomics 2011, 10. [CrossRef] [PubMed].
36. Gong, P.; Madak-Erdogan, Z.; Li, J.; Cheng, J.; Greenlief, C.M.; Helferich, W.G.; Katzenellenbogen, J.A.; Katzenellenbogen, B.S. Transcriptomic analysis identifies gene networks regulated by estrogen receptor alpha (ERalpha) and ERbeta that control distinct effects of different botanical estrogens. Nucl. Recept. Signal. 2014, 12. [CrossRef] [PubMed].
37. Huang, B.; Omoto, Y.; Iwase, H.; Yamashita, H.; Toyama, T.; Coombes, R.C.; Filipovic, A.; Warner, M.; Gustafsson, J.A. Differential expression of estrogen receptor alpha, beta1, and beta2 in lobular and ductal breast cancer. Proc. Natl. Acad. Sci. USA 2014, 111, 1933-1938. [CrossRef] [PubMed].
38. Hwang, C.S.; Kwak, H.S.; Lim, H.J.; Lee, S.H.; Kang, Y.S.; Choe, T.B.; Hur, H.G.; Han, K.O. Isoflavone metabolites and their in vitro dual functions: They can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J. Steroid Biochem. 2006, 101, 246-253. [CrossRef] [PubMed].
39. Chen, F.P.; Chien, M.H.; Chern, I.Y. Impact of lower concentrations of phytoestrogens on the effects of estradiol in breast cancer cells. Climacteric 2015, 18, 574-581. [CrossRef] [PubMed].
40. Obiorah, I.E.; Fan, P.; Jordan, V.C. Breast cancer cell apoptosis with phytoestrogens is dependent on an estrogen-deprived state. Cancer Prev. Res. 2014, 7, 939-949. [CrossRef] [PubMed].
41. Berthois, Y.; Katzenellenbogen, J.A.; Katzenellenbogen, B.S. Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. USA 1986, 83, 2496-2500. [CrossRef] [PubMed].
42. Hsieh, C.Y.; Santell, R.C.; Haslam, S.Z.; Helferich, W.G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 1998, 58, 3833-3838. [PubMed].
43. Maggiolini, M.; Bonofiglio, D.; Marsico, S.; Panno, M.L.; Cenni, B.; Picard, D.; Ando, S. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol. Pharmacol. 2001, 60, 595-602. [PubMed].
44. Allred, C.D.; Allred, K.F.; Ju, Y.H.; Virant, S.M.; Helferich, W.G. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res. 2001, 61, 5045-5050. [PubMed].
45. Choi, E.J.; Jung, J.Y.; Kim, G.H. Genistein inhibits the proliferation and differentiation of MCF-7 and 3T3-L1 cells via the regulation of ERalpha expression and induction of apoptosis. Exp. Ther. Med. 2014, 8, 454-458. [PubMed].
46. Choi, E.J.; Kim, G.H. Antiproliferative activity of daidzein and genistein may be related to ERalpha/c-erbb-2 expression in human breast cancer cells. Mol. Med. Rep. 2013, 7, 781-784. [PubMed].
47. Theil, C.; Briese, V.; Gerber, B.; Richter, D.U. The effects of different lignans and isoflavones, tested as aglycones and glycosides, on hormone receptor-positive and -negative breast carcinoma cells in vitro. Arch. Gynecol. Obstet. 2011, 284, 459-465. [CrossRef] [PubMed].
48. Rajah, T.T.; Peine, K.J.; Du, N.; Serret, C.A.; Drews, N.R. Physiological concentrations of genistein and 17beta-estradiol inhibit MDA-MB-231 breast cancer cell growth by increasing BAX/BCL-2 and reducing pERK1/2. Anticancer Res. 2012, 32, 1181-1191. [PubMed].
49. Maggiolini, M.; Vivacqua, A.; Fasanella, G.; Recchia, A.G.; Sisci, D.; Pezzi, V.; Montanaro, D.; Musti, A.M.; Picard, D.; Ando, S. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. J. Biol. Chem. 2004, 279, 27008-27016. [CrossRef] [PubMed].
50. Lucki, N.C.; Sewer, M.B. Genistein stimulates MCF-7 breast cancer cell growth by inducing acid ceramidase (ASAH1) gene expression. J. Biol. Chem. 2011, 286, 19399-19409. [CrossRef] [PubMed].
51. Yang, S.; Zhou, Q.; Yang, X. Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells. BBA-Mol. Cell. Res. 2007, 1773, 903-911. [CrossRef] [PubMed].
52. Charalambous, C.; Pitta, C.A.; Constantinou, A.I. Equol enhances tamoxifen's anti-tumor activity by induction of caspase-mediated apoptosis in MCF-7 breast cancer cells. BMC Cancer 2013, 13. [CrossRef] [PubMed].
53. Jin, S.; Zhang, Q.Y.; Kang, X.M.;Wang, J.X.; Zhao, W.H. Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway. Ann. Oncol. 2010, 21, 263-268. [CrossRef] [PubMed].
54. Shim, H.Y.; Park, J.H.; Paik, H.D.; Nah, S.Y.; Kim, D.S.; Han, Y.S. Genistein-induced apoptosis of human breast cancer MCF-7 cells involves calpain-caspase and apoptosis signaling kinase 1-p38 mitogen-activated protein kinase activation cascades. Anti-Cancer drug. 2007, 18, 649-657. [CrossRef] [PubMed].
55. Sakamoto, T.; Horiguchi, H.; Oguma, E.; Kayama, F. Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells. J. Nutr. Biochem. 2010, 21, 856-864. [CrossRef] [PubMed].
56. Kazi, A.; Daniel, K.G.; Smith, D.M.; Kumar, N.B.; Dou, Q.P. Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein. Biochem. Pharmacol. 2003, 66, 965-976. [CrossRef].
57. Tsuboy, M.S.; Marcarini, J.C.; de Souza, A.O.; de Paula, N.A.; Dorta, D.J.; Mantovani, M.S.; Ribeiro, L.R. Genistein at maximal physiologic serum levels induces G0/G1 arrest in MCF-7 and HB4a cells, but not apoptosis. J. Med. Food 2014, 17, 218-225. [CrossRef] [PubMed].
58. Zhou, Y.; Eppenberger-Castori, S.; Marx, C.; Yau, C.; Scott, G.K.; Eppenberger, U.; Benz, C.C. Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers. Int. J. Biochem. Cell. B 2005, 37, 1130-1144. [CrossRef] [PubMed].
59. Zubair, A.; Frieri, M. Role of nuclear factor-kB in breast and colorectal cancer. Curr. Allergy Asthm. Rep. 2013, 13, 44-49. [CrossRef] [PubMed].
60. Baumgarten, S.C.; Frasor, J. Minireview: Inflammation: An instigator of more aggressive estrogen receptor (ER) positive breast cancers. Mol. Endocrinol. 2012, 26, 360-371. [CrossRef] [PubMed].
61. Seo, H.S.; Choi, H.S.; Choi, H.S.; Choi, Y.K.; Um, J.Y.; Choi, I.; Shin, Y.C.; Ko, S.G. Phytoestrogens induce apoptosis via extrinsic pathway, inhibiting nuclear factor-kappaB signaling in HER2-overexpressing breast cancer cells. Anticancer Res. 2011, 31, 3301-3313. [PubMed].
62. O'Toole, S.A.; Beith, J.M.; Millar, E.K.; West, R.; McLean, A.; Cazet, A.; Swarbrick, A.; Oakes, S.R. Therapeutic targets in triple negative breast cancer. J. Clin. Pathol. 2013, 66, 530-542. [CrossRef] [PubMed].
63. Polivka, J. Jr.; Janku, F. Molecular targets for cancer therapy in the PI3K/AKT/MTOR pathway. Pharmacol. Ther. 2014, 142, 164-175. [CrossRef] [PubMed].
64. Ciruelos Gil, E.M. Targeting the PI3K/AKT/MTOR pathway in estrogen receptor-positive breast cancer. Cancer Treat. Rev. 2014, 40, 862-871. [CrossRef] [PubMed].
65. Lopez-Knowles, E.; O'Toole, S.A.; McNeil, C.M.; Millar, E.K.; Qiu, M.R.; Crea, P.; Daly, R.J.; Musgrove, E.A.; Sutherland, R.L. PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality. Int. J. Cancer 2010, 126, 1121-1131. [CrossRef] [PubMed].
66. Chen, J.; Duan, Y.; Zhang, X.; Ye, Y.; Chen, J. Genistein induces apoptosis by inactivation of IGF-1R/P-AKT signaling pathway in MCF-7 human breast cancer cells. Food Funct. 2015, 6, 995-1000. [CrossRef] [PubMed].
67. Chen, W.F.; Gao, Q.G.;Wong, M.S. Mechanism involved in genistein activation of insulin-like growth factor 1 receptor expression in human breast cancer cells. Br. J. Nutr. 2007, 98, 1120-1125. [CrossRef] [PubMed].
68. Rahal, O.M.; Simmen, R.C. PTEN and p53 cross-regulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation. Carcinogenesis 2010, 31, 1491-1500. [CrossRef] [PubMed].
69. Li, D.; Feng, J.; Wu, T.; Wang, Y.; Sun, Y.; Ren, J.; Liu, M. Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma. Am. J. Pathol. 2013, 182, 64-70. [CrossRef] [PubMed].
70. Wu, Y.; Zhang, L.;Wang, Y.; Li, H.; Ren, X.;Wei, F.; Yu, W.;Wang, X.; Zhang, L.; Yu, J.; et al. Long noncoding RNA HOTAIR involvement in cancer. Tumour Biol. 2014, 35, 9531-9538. [CrossRef] [PubMed].
71. Chen, J.; Lin, C.; Yong, W.; Ye, Y.; Huang, Z. Calycosin and genistein induce apoptosis by inactivation of HOTAIR/P-Akt signaling pathway in human breast cancer MCF-7 cells. Cell Physiol. Biochem. 2015, 35, 722-728. [PubMed].
72. Anastasius, N.; Boston, S.; Lacey, M.; Storing, N.; Whitehead, S.A. Evidence that low-dose, long-term genistein treatment inhibits oestradiol-stimulated growth in MCF-7 cells by down-regulation of the PI3-kinase/Akt signalling pathway. J. Steroid Biochem. 2009, 116, 50-55. [CrossRef] [PubMed].
73. Ahmad, A.; Biersack, B.; Li, Y.; Kong, D.; Bao, B.; Schobert, R.; Padhye, S.B.; Sarkar, F.H. Deregulation of PI3K/Akt/mTOR signaling pathways by isoflavones and its implication in cancer treatment. Anticancer Agents Med. Chem. 2013, 13, 1014-1024. [CrossRef] [PubMed].
74. Saini, K.S.; Loi, S.; de Azambuja, E.; Metzger-Filho, O.; Saini, M.L.; Ignatiadis, M.; Dancey, J.E.; Piccart-Gebhart, M.J. Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways in the treatment of breast cancer. Cancer Treat. Rev. 2013, 39, 935-946. [CrossRef] [PubMed].
75. Ma, J.; Lyu, H.; Huang, J.; Liu, B. Targeting of erbB3 receptor to overcome resistance in cancer treatment. Mol. Cancer 2014, 13. [CrossRef] [PubMed].
76. Liu, H.; Du, J.; Hu, C.; Qi, H.; Wang, X.; Wang, S.; Liu, Q.; Li, Z. Delayed activation of extracellular-signal-regulated kinase 1/2 is involved in genistein- And equol-induced cell proliferation and estrogen-receptor-alpha-mediated transcription in MCF-7 breast cancer cells. J. Nutr. Biochem. 2010, 21, 390-396. [CrossRef] [PubMed].
77. Yang, X.; Yang, S.; McKimmey, C.; Liu, B.; Edgerton, S.M.; Bales, W.; Archer, L.T.; Thor, A.D. Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation. Carcinogenesis 2010, 31, 695-702. [CrossRef] [PubMed].
78. Hoff, P.M.; Machado, K.K. Role of angiogenesis in the pathogenesis of cancer. Cancer Treat. Rev. 2012, 38, 825-833. [CrossRef] [PubMed].
79. Berman, A.T.; Thukral, A.D.; Hwang, W.T.; Solin, L.J.; Vapiwala, N. Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment. Clin. Breast Cancer 2013, 13, 88-94. [CrossRef] [PubMed].
80. Fotsis, T.; Pepper, M.; Adlercreutz, H.; Fleischmann, G.; Hase, T.; Montesano, R.; Schweigerer, L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA 1993, 90, 2690-2694. [CrossRef] [PubMed].
81. Kim, M.H. Flavonoids inhibit VEGF/BFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. J. Cell. Biochem. 2003, 89, 529-538. [CrossRef] [PubMed].
82. Buteau-Lozano, H.; Velasco, G.; Cristofari, M.; Balaguer, P.; Perrot-Applanat, M. Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism. J. Endocrinol. 2008, 196, 399-412. [CrossRef] [PubMed].
83. Hsu, E.L.; Chen, N.;Westbrook, A.;Wang, F.; Zhang, R.; Taylor, R.T.; Hankinson, O. Modulation of CXCR4, CXCL12, and tumor cell invasion potential in vitro by phytochemicals. J. Oncol. 2009, 2009. [CrossRef] [PubMed].
84. Lee, W.Y.; Huang, S.C.; Tzeng, C.C.; Chang, T.L.; Hsu, K.F. Alterations of metastasis-related genes identified using an oligonucleotide microarray of genistein-treated HCC1395 breast cancer cells. Nutr. Cancer 2007, 58, 239-246. [CrossRef] [PubMed].
85. Magee, P.J.; Allsopp, P.; Samaletdin, A.; Rowland, I.R. Daidzein, R-(+)equol and S-(-)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2. Eur. J. Nutr. 2014, 53, 345-350. [CrossRef] [PubMed].
86. Phromnoi, K.; Yodkeeree, S.; Anuchapreeda, S.; Limtrakul, P. Inhibition of MMP-3 activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids. Acta Pharmacol. Sin. 2009, 30, 1169-1176. [CrossRef] [PubMed].
87. Yang, X.; Belosay, A.; Hartman, J.A.; Song, H.; Zhang, Y.; Wang, W.; Doerge, D.R.; Helferich, W.G. Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors. Clin. Exp. Metastas. 2015, 32, 323-333. [CrossRef] [PubMed].
88. Mahmoud, A.M.; Yang, W.; Bosland, M.C. Soy isoflavones and prostate cancer: A review of molecular mechanisms. J. Steroid Biochem. 2014, 140, 116-132. [CrossRef] [PubMed].
89. Devi, G.R.; Allensworth, J.L.; Evans, M.K.; Sauer, S.J. The Role of Oxidative Stress in Breast Cancer. In Cancer; Preedy, V., Ed.; Academic Press: San Diego, CA, USA, 2014; Chapter 1; pp. 3-14.
90. Mencalha, A.; Victorino, V.J.; Cecchini, R.; Panis, C. Mapping oxidative changes in breast cancer: understanding the basic to reach the clinics. Anticancer Res. 2014, 34, 1127-1140. [PubMed].
91. Sastre-Serra, J.; Valle, A.; Company, M.M.; Garau, I.; Oliver, J.; Roca, P. Estrogen down-regulates uncoupling proteins and increases oxidative stress in breast cancer. Free Radic. Biol. Med. 2010, 48, 506-512. [CrossRef] [PubMed].
92. Nadal-Serrano, M.; Sastre-Serra, J.; Pons, D.G.; Miro, A.M.; Oliver, J.; Roca, P. The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol. J. Cell. Biochem. 2012, 113, 3178-3185. [CrossRef] [PubMed].
93. Ullah, M.F.; Ahmad, A.; Zubair, H.; Khan, H.Y.; Wang, Z.; Sarkar, F.H.; Hadi, S.M. Soy isoflavone genistein induces cell death in breast cancer cells through mobilization of endogenous copper ions and generation of reactive oxygen species. Mol. Nutr. Food Res. 2011, 55, 553-559. [CrossRef] [PubMed].
94. Choi, J.N.; Kim, D.; Choi, H.K.; Yoo, K.M.; Kim, J.; Lee, C.H. 21-hydroxylation of genistein enhanced antioxidant and antiproliferative activities in mcf-7 human breast cancer cells. J. Microbiol. Biotechnnol. 2009, 19, 1348-1354. [CrossRef].
95. Xie, Q.; Bai, Q.; Zou, L.Y.; Zhang, Q.Y.; Zhou, Y.; Chang, H.; Yi, L.; Zhu, J.D.; Mi, M.T. Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells. Gene Chromosome Cancer 2014, 53, 422-431. [CrossRef] [PubMed].
96. Dagdemir, A.; Durif, J.; Ngollo, M.; Bignon, Y.J.; Bernard-Gallon, D. Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines. Epigenomics 2013, 5, 51-63. [CrossRef] [PubMed].
97. Liu, X.; Sun, C.; Jin, X.; Li, P.; Ye, F.; Zhao, T.; Gong, L.; Li, Q. Genistein enhances the radiosensitivity of breast cancer cells via G(2)/M cell cycle arrest and apoptosis. Molecules 2013, 18, 13200-13217. [CrossRef] [PubMed].
98. Xue, J.P.; Wang, G.; Zhao, Z.B.; Wang, Q.; Shi, Y. Synergistic cytotoxic effect of genistein and doxorubicin on drug-resistant human breast cancer MCF-7/Adr cells. Oncol. Rep. 2014, 32, 1647-1653. [CrossRef] [PubMed].
99. Lattrich, C.; Lubig, J.; Springwald, A.; Goerse, R.; Ortmann, O.; Treeck, O. Additive effects of trastuzumab and genistein on human breast cancer cells. Anti-Cancer Drug. 2011, 22, 253-261. [CrossRef] [PubMed].
100. Engel, N.; Lisec, J.; Piechulla, B.; Nebe, B. Metabolic profiling reveals sphingosine-1-phosphate kinase 2 and lyase as key targets of (phyto-) estrogen action in the breast cancer cell line MCF-7 and not in MCF-12A. PLoS ONE 2012, 7. [CrossRef] [PubMed].
101. Phan, V.; Walters, J.; Brownlow, B.; Elbayoumi, T. Enhanced cytotoxicity of optimized liposomal genistein via specific induction of apoptosis in breast, ovarian and prostate carcinomas. J. Drug Target. 2013, 21, 1001-1011. [CrossRef] [PubMed].
102. Zhang, H.; Liu, G.; Zeng, X.; Wu, Y.; Yang, C.; Mei, L.; Wang, Z.; Huang, L. Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells. Int. J. Nanomed. 2015, 10, 2461-2473.
103. Spoerlein, C.; Mahal, K.; Schmidt, H.; Schobert, R. Effects of chrysin, apigenin, genistein and their homoleptic copper(II) complexes on the growth and metastatic potential of cancer cells. J. Inorg. Biochem. 2013, 127, 107-115. [CrossRef] [PubMed].
104. Rusin, A.; Zawisza-Puchalka, J.; Kujawa, K.; Gogler-Piglowska, A.; Wietrzyk, J.; Switalska, M.; Glowala-Kosinska, M.; Gruca, A.; Szeja, W.; Krawczyk, Z.; et al. Synthetic conjugates of genistein affecting proliferation and mitosis of cancer cells. Bioorg. Med. Chem. 2011, 19, 295-305. [CrossRef] [PubMed].
105. Switalska, M.; Grynkiewicz, G.; Strzadala, L.;Wietrzyk, J. Novel genistein derivatives induce cell death and cell cycle arrest through different mechanisms. Nutr. Cancer 2013, 65, 874-884. [CrossRef] [PubMed].
106. Ahmad, A.; Ginnebaugh, K.R.; Li, Y.; Padhye, S.B.; Sarkar, F.H. Molecular targets of naturopathy in cancer research: Bridge to modern medicine. Nutrients 2015, 7, 321-334. [CrossRef] [PubMed].